Fabian Tenenbaum - Chief Executive Officer, Bellerophon Therapeutics, Inc

As of November 19, 2019


Fabian Tenenbaum Net Worth

  • Net worth is estimated to be at least $1.95M
  • Owns at least 484,282 units of Bellerophon Therapeutics, Inc stock
  • Sold an estimated value of $176.58K in the last 3 years at Bellerophon Therapeutics, Inc

Fabian Tenenbaum Trading

  • Largest purchase of shares was 5,000 units , worth over $2.98K on May 22, 2019
  • In total has made about 13 transactions over 3 years
  • Usually trades in November, with the busiest year in 2016, 2018 and 2019
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Fabian Tenenbaum Mailing Address

  • Mailing address is 60 East 42nd Street, Suite 1160 New York NY 10165 NY

Bellerophon Therapeutics, Inc Insider Trading

  • The most recent transaction was 400,000 units sold on March 22, 2021 by New Mountain Investments Ii Llc, New Mountain Capital Llc and Steven Klinsky worth over $2.19M
  • In the last 6 years, insiders at Bellerophon Therapeutics, Inc sold an estimated value of $3.99M and bought an estimated value of $74.83M
  • The most active traders are Jonathan M Peacock,  Theodore Wang, Director,  and Fabian Tenenbaum, Chief Executive Officer
  • Insider trading is most common in September, with the busiest year in 2018

Bellerophon Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1